Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Tables)

v3.8.0.1
Earnings (Loss) Per Common Share (Tables)
 3 Months Ended
Sep. 30, 2017
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following table summarizes the components of the earnings (loss) per common share calculation (in thousands, except per share amounts):
 
 
 
Three Months ended
September 30,
 
 
 
2017
 
2016
 
Basic and diluted numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to iBio, Inc. stockholders
 
$
(3,826)
 
$
(3,061)
 
Preferred stock dividends
 
 
(66)
 
 
—
 
Net loss available to iBio, Inc. stockholders
 
$
(3,892)
 
$
(3,061)
 
 
 
 
 
 
 
 
 
Basic and diluted denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average common shares outstanding
 
 
91,853
 
 
89,109
 
 
 
 
 
 
 
 
 
Per share amount
 
$
(0.04)
 
$
(0.03)